Psilocybin Treatments for Treatment-Resistant Depression with Compass Pathways’ Dr. Steve Levine
March 25, 202621 min
Show notes
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Steve Levine, MD, Chief Patient Officer at Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. One of the areas that Compass Pathways is working in is the development of psilocybin-based treatments for treatment-resistant depression (TRD). Dr. Levine is a board-certified psychiatrist who has spent his career working across multiple facets of the healthcare system to improve people’s lives through creating access to innovation. Dr. Levine completed an internship and residency in psychiatry at New York – Presbyterian Hospital/Weill Cornell Medical Center, followed by fellowship subspecialty training in psychosomatic medicine/psycho-oncology at Memorial Sloan Kettering Cancer Center/New York – Presbyterian Hospital. Prior to Compass Pathways, Dr. Levine led Actify Neurotherapies, a company he founded in 2010 that built new models of care delivery across the US for interventional psychiatry treatments. He has published extensively in both peer-reviewed journals and popular media, presented to both professional and lay audiences around the world, served in leadership roles for professional societies and not-for-profit entities and received numerous awards for leadership and service. Tune in to hear about innovations and unmet needs in the mental health space and the development of science-driven psilocybin-based treatments for depression. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Transcript
Transcript not available for this episode yet.
More from Xtalks Life Science Podcast
Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò
Jun 10, 202624 min
What’s Next in Cardiometabolic Disease Drug Development: Obesity, MASH and Beyond with MetaVia’s Hyung Heon Kim
Jun 4, 202626 min
How Real-World Evidence Is Shaping Inclusive Clinical Trials with Takeda CMO Dr. Awny Farajallah
May 27, 202637 min
Stem Cell Therapies for Degenerative Disc Disease and More with BioRestorative’s Lance Alstodt
May 20, 202638 min
New Blood Test for Early Alzheimer’s Detection with FNIH’s Dr. Alessio Travaglia
May 13, 202630 min